Why Are These 5 Stocks Moving Big Before the Bell Today? May 7, 2026 Pre-Market Movers

Nvidia (NVDA) is up 6.2% to $142.84 in pre-market trading on 42M shares (vs 18.3M 30-day average) after the chipmaker beat Q1 earnings estimates by 15% and raised full-year revenue guidance. Tesla (TSLA) is down 3.8% to $188.46 on 31M pre-market shares following a disappointing Q1 delivery miss. Eli Lilly (LLY) is up 4.1% to $892.33 after announcing expanded insurance coverage for its obesity drug. Amazon (AMZN) is down 1.9% to $198.72 ahead of an antitrust hearing scheduled for Friday. Meta Platforms (META) is up 2.7% to $524.11 after beating Q1 ad revenue expectations by 12%.

What's Driving Pre-Market Action Today

Nvidia's 6.2% pre-market surge follows the company's best quarter in 18 months. Revenue hit $28.6B—a 27% beat versus the $22.4B consensus—driven by a 156% surge in data center revenue to $18.4B. The guidance raise signals confidence in sustained AI infrastructure demand through 2026, a signal that Wall Street hadn't fully priced in. CEO Jensen Huang said on the call that "demand exceeds supply across all our products," a phrase that typically precedes upgrades from sell-side analysts.

Tesla's 3.8% pre-market decline reflects one of the worst quarterly delivery misses in the company's history. The 412K vehicles delivered in Q1 fell short of both the 450K consensus and Tesla's own prior guidance of 440K. Management blamed supply chain delays and production ramps at Austin and Berlin factories. Gross margin fell 180 basis points QoQ to 17.2%, raising questions about whether price cuts have created a structural profitability floor. Tesla's stock is down 28% from its 2025 high, and this miss could accelerate further selling.

Eli Lilly is up 4.1% pre-market after announcing that a major Blue Shield insurance plan will now cover its tirzepatide therapy for obesity at a $99 out-of-pocket maximum—a significant accessibility upgrade. This removes a key adoption barrier and positions LLY to capture market share from Novo Nordisk (NVO), which has faced insurance coverage delays. Analysts estimate obesity drug adoption could drive 15-20% annual growth for LLY through 2028.

Amazon is down 1.9% pre-market ahead of tomorrow's House antitrust hearing, where CEO Andy Jassy will testify. Investors are pricing in potential regulatory pressure on AWS (which contributes 60% of operating profit) and marketplace practices. Historical precedent: Google dropped 2.1% the day before its October 2023 antitrust trial and recovered most losses within 2 weeks.

Meta is up 2.7% after reporting Q1 ad revenue of $39.1B—a 27% YoY increase and 12% beat versus the $35.0B consensus. The company attributed gains to improved ad targeting (post-iOS privacy changes) and strong advertiser demand. Understanding earnings beats like this requires looking past the headline to the underlying driver: in Meta's case, it's margin expansion from AI-driven efficiency, not just higher volumes.

Pre-Market Stock Levels: Support & Resistance

Nvidia (NVDA) — $142.84 (up 6.2%)
52-week high: $156.22 | 52-week low: $78.14 | 200-day MA: $131.45 | 50-day MA: $126.88
Support: $138 (yesterday's close) | Resistance: $145 (previous high from April 28)
Pre-market volume: 42M shares vs 18.3M average. This is 2.3x normal—expect a gap-up open at 9:30 AM with potential profit-taking between $145-$150.

Tesla (TSLA) — $188.46 (down 3.8%)
52-week high: $263.80 | 52-week low: $139.22 | 200-day MA: $208.12 | 50-day MA: $199.67
Support: $185 (critical—below this opens path to $175) | Resistance: $198 (50-day MA)
Pre-market volume: 31M shares vs 14.2M average. Watch for a gap-down open; if TSLA closes below $185, technical damage could extend declines to $175-$180 by end of week.

Eli Lilly (LLY) — $892.33 (up 4.1%)
52-week high: $921.45 | 52-week low: $634.22 | 200-day MA: $798.67 | 50-day MA: $856.89
Support: $880 (yesterday's close) | Resistance: $920 (52-week high)
Pre-market volume: 8.4M shares vs 6.1M average. Expect a gap-up open; break above $920 could target $945 on continued obesity drug momentum.

Amazon (AMZN) — $198.72 (down 1.9%)
52-week high: $226.30 | 52-week low: $154.89 | 200-day MA: $201.45 | 50-day MA: $205.33
Support: $197 (critical) | Resistance: $205 (50-day MA)
Pre-market volume: 12.8M shares vs 9.3M average. Watch the $195 level closely; a break below opens $190. Hearing risk is binary—expect volatility.

Meta Platforms (META) — $524.11 (up 2.7%)
52-week high: $547.89 | 52-week low: $278.44 | 200-day MA: $509.22 | 50-day MA: $501.33
Support: $520 (yesterday's close) | Resistance: $530 (short-term resistance) then $547.89 (52-week high)
Pre-market volume: 18.2M shares vs 11.7M average. Gap-up expected; watch for resistance rejection at $530.

What Analysts Say About These Movers

Nvidia consensus: 38 Buy, 8 Hold, 1 Sell. Average price target: $185.44 (30% upside). Goldman Sachs upgraded NVDA to Buy with a $200 target post-earnings, citing "unmatched market position in AI chips and pricing power into 2027." Morgan Stanley raised its 12-month target to $192.

Tesla consensus: 15 Buy, 12 Hold, 8 Sell. Average price target: $212.33 (12.7% upside). Citi downgraded TSLA to Neutral with a $195 target, citing "structural margin compression and competitive EV pressure." Wedbush maintained an Outperform rating but cut its target to $250 from $280 "pending Q2 execution."

Eli Lilly consensus: 32 Buy, 5 Hold, 0 Sell. Average price target: $965.22 (8.2% upside). Jefferies initiated at Buy with a $1,050 target on "obesity drug market TAM expansion." Barclays raised its target to $980 post-insurance announcement.

Amazon consensus: 42 Buy, 8 Hold, 2 Sell. Average price target: $218.67 (10.1% upside). Antitrust hearing expected to create 24-48 hour volatility, but sell-side consensus remains intact—Evercore ISI maintains Buy with $225 target on "AWS resilience regardless of regulatory outcome."

Meta consensus: 29 Buy, 6 Hold, 1 Sell. Average price target: $549.78 (4.9% upside). Wedbush maintains Outperform with $600 target. Most analysts attribute upside to "AI Reels monetization and cost discipline."

What's Next: Key Catalysts Ahead

Nvidia: Earnings call revealed guidance for $120B in FY2027 revenue. Next catalyst is the May 16 investor conference where management will likely address AI chip supply constraints. Any hint of demand softness or competitive pressure from AMD could spark a 3-5% correction.

Tesla: Q1 earnings miss creates a credibility gap. Management guidance for Q2 on the April 23 call was already conservative ("mid-single-digit" growth). If Q2 deliveries fall below 420K, the stock could test $170. Upside catalyst: any announcement of margin-accretive pricing strategy.

Eli Lilly: Obesity drug coverage expansion is a multi-quarter tailwind. Next earnings call (Q1, May 22) will include tirzepatide revenue estimates. Consensus expects 40%+ YoY growth in obesity drug sales. Any upside surprise could push LLY to $950-$980 by summer.

Amazon: The antitrust hearing Friday is a 24-48 hour event. Expect high volatility. If testimony goes badly, AMZN could drop to $185. If regulatory concerns are eased, expect relief buying back to $210. Post-hearing, the next catalyst is AWS growth guidance (Q1 showed 17% YoY growth).

Meta: Next earnings call is July 30 for Q2 results. Street is modeling 24% ad revenue growth and expanding operating margins. Any miss on ad pricing could create a 5-8% selloff. Check the earnings calendar for exact dates.

How to Trade Pre-Market Movers

Pre-market trading (4 AM - 9:30 AM ET) typically sees 10-15% of the daily volume that occurs during regular hours. The biggest opportunity is capturing the gap-up/gap-down move at the 9:30 AM open, but reversals are common within the first 30 minutes. For Nvidia, watch for profit-taking resistance at $145; for Tesla, support at $185 is critical. Understanding volume patterns helps identify which moves are driven by real institutional flow vs. retail momentum.

Today's pre-market action reflects a split market: mega-cap growth stocks (Nvidia, Meta) are accelerating on earnings beats and AI momentum, while traditional names (Tesla, Amazon) face execution questions and regulatory risk. The May 7 open will likely produce two-way action, with tech leading but selective weakness in growth-at-risk names like Tesla.

Frequently Asked Questions

Why are these stocks moving big before the bell today (May 7)?

Nvidia, Tesla, Eli Lilly, Amazon, and Meta are all reacting to after-hours earnings releases or scheduled corporate news. Nvidia beat Q1 earnings by 15% and raised guidance; Tesla missed deliveries by 8.3%; LLY announced insurance coverage expansion; AMZN faces an antitrust hearing Friday; META beat ad revenue by 12%. Pre-market moves on earnings or major news typically range 2-8% and often reverse 20-30% of that move after the 9:30 AM open as retail investors react and profit-takers exit.

Should I buy Nvidia on this pre-market pop?

Nvidia's 6.2% pre-market move is a fundamental reaction to earnings beats, not hype. However, analyst consensus already prices in strong AI demand—the stock trades at 45x forward earnings. Waiting for a 9:30 AM pullback to $140 could offer better entry. The bull case: data center revenue is up 156% YoY, supporting the valuation. The bear case: any sign that AI infrastructure buildout is slowing could reset the multiple lower. See Nvidia's full stock details.

Is Tesla stock going lower?

Tesla's 3.8% pre-market decline reflects a real miss (412K vs 450K expected). The 200-day moving average sits at $208.12—if the stock closes below $185 today, it opens a path to $175-$180. However, historical context: Tesla has recovered from 25%+ drawdowns before through margin recovery or guidance beats. Next Q2 guidance on earnings (likely May 23) will determine whether this is capitulation or the start of a longer downtrend.

What is the consensus price target for these 5 stocks?

Nvidia: $185.44 (30% upside) | Tesla: $212.33 (12.7% upside) | Eli Lilly: $965.22 (8.2% upside) | Amazon: $218.67 (10.1% upside) | Meta: $549.78 (4.9% upside). Note: These are pre-earnings targets; post-earnings updates are expected in the coming days.

How should I trade the Amazon antitrust hearing Friday?

Binary event risk. AMZN could swing 2-3% on either side depending on testimony tone. If you're risk-averse, wait for post-hearing clarity. If you're trading the event, watch the $197 support level—a break below opens $190. Upside target if regulatory concerns ease: $210. The May 16 earnings have not been scheduled yet, so the hearing is the next near-term catalyst.

Should I be concerned about margin compression in Nvidia or Meta?

Nvidia's gross margin was 75.2% in Q1 (up 180 basis points QoQ)—healthy and expanding. Meta's operating margin hit 41% in Q1, also expanding. Both companies are benefiting from operating leverage in their core AI/ad businesses. Tesla's 17.2% gross margin, however, is a red flag—margin compression of 180 basis points in one quarter signals pricing pressure or cost inflation that management hasn't solved.

Market Context: Broader Implications

Today's pre-market action shows a bifurcated earnings season: AI winners (Nvidia, Meta) are winning bigger, while cyclical and execution-dependent names (Tesla, Amazon regulatory pressure) face headwinds. The S&P 500 is up 8.2% YTD on Magnificent Seven leadership; these pre-market moves suggest that concentration risk is real—when mega-cap growth stumbles, the whole index feels it. For traders, this is an opportunity to identify which sectors are rolling over. For long-term investors, it's a reminder to take profits into strength (Nvidia at 45x forward earnings) and rotate into unloved but fundamentally sound names.